Harrow Inc reports results for the quarter ended in March - Earnings Summary

Harrow

13/05/2024 22:52

* Harrow Inc  HROW.OQ  reported a quarterly adjusted loss
of 38
cents​​ per share for the quarter ended in March, lower than the
same quarter last year, when the company reported EPS of -22
cents.  The mean expectation of four analysts for the quarter
was for a loss of 20 cents per share. Wall Street expected
results to range from -27 cents to -6 cents per share.
    * Revenue rose 32.5% to $34.59 million from a year ago;
analysts
expected $36.32 million. 
    * Harrow Inc's reported EPS for the quarter was a loss of 38
cents​.
    * The company reported a quarterly loss of $13.57 million.
    * Harrow Inc shares had fallen by 12.3% this quarter and
gained 3.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 2,976.9% in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Harrow Inc is
$25.00 
This summary was machine generated from LSEG data May 13 at
09:52 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.20          -0.38          Missed
 Dec. 31 2023      -0.04          -0.25          Missed
 Sep. 30 2023      0.04           -0.13          Missed
 Jun. 30 2023      -0.04          -0.14          Missed